Friday - December 12, 2025

Category Archives: Financial Market

Kartoon Studios (NYSE: TOON) Climbing as Netflix-Paramount Battle for Warner Bros. Sparks Speculation – More Inside

Kartoon Studios (NYSE: TOON) has climbed 37.93% since November 20, 2025, following a strong close on elevated trading volume, as speculation intensifies that the company could emerge as a potential acquisition target amid Hollywood’s escalating takeover war. Along with Kartoon … Continue reading →

Why Synergy (NASDAQ: SNYR) Could Hit $7 Sooner Than Expected – Beverage Rollout Ignites 2026 Growth Acceleration

Synergy CHC Corp. (NASDAQ: SNYR) is drawing renewed attention after Roth Capital Partners reaffirmed its Buy rating and issued a $7 price target, citing strong fundamentals, a growing product portfolio, and a new phase of revenue acceleration driven by the … Continue reading →

Actinium Pharmaceuticals Advances Trop-2 Targeted Alpha Radiotherapy Into Phase 1/2 Trials in the U.S. and Australia

Actinium Pharmaceuticals (NYSE American: ATNM) is advancing its Trop-2–targeted ATNM-400 construct into Phase 1/2 trials across the United States and Australia, marking an important step as the company broadens its presence in solid-tumor radiopharmaceuticals. With targeted alpha radiotherapy gaining momentum … Continue reading →

Game-Changing News: BEAT, APRE, TOON, MNTS, PRSO, PNPNF, SIGL – Stocks Under $1 Look Now

A wave of breakthrough developments across medical technology, cybersecurity, entertainment, space defense, semiconductor innovation, and critical minerals is putting several sub-$1 stocks on the radar of retail and institutional investors. Below is a complete rundown of seven major catalysts driving … Continue reading →

Actinium Pharmaceuticals (NYSEAMERICAN: ATNM) Begins European Phase 1 Trial of Nectin-4 Targeted Alpha Therapy for Multiple Solid Tumors

Innovation in oncology continues to accelerate, with global cancer R&D spending now exceeding hundreds of billions annually and more than a thousand new trials launched each year. Among the fastest-growing segments is radiopharmaceuticals, attracting significant investment as major pharmaceutical companies … Continue reading →